Abaxis To Report Third Quarter Fiscal Year 2015 Financial Results Thursday, January 29, 2015

UNION CITY, Calif., Jan. 16, 2015 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care instruments and consumables for the medical, research, and veterinary markets worldwide and providing reference lab services to the veterinary and research markets in the United States, has scheduled a conference call to discuss its financial results for the third quarter fiscal year 2015, ended December 31, 2014. The call will be at 4:15 p.m. ET on Thursday, January 29, 2015.  The Company will report financial results for the third quarter fiscal year 2015 after the market closes on Thursday, January 29, 2015.

Participants can dial [phone] or [phone] to access the conference call, or can listen via a live Internet web cast, which is available in the Investor Relations section of the Company's website at www.abaxis.com. A replay of the call is available by visiting www.abaxis.com for the next 30 days or by calling [phone] or [phone], confirmation code 10058425, through February 4, 2015.

About Abaxis
Abaxis develops, manufactures, markets and sells portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements.  The system consists of a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs that contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients.  The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma samples.  The system provides test results in less than 12 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer.  The veterinary business also provides to the animal health and research market a line of hematology instruments for point-of-care complete blood counts (CBC), a specialty instrument to screen for and detect clotting disorders and to measure equine fibrinogen levels, a handheld instrument for the rapid assessment of certain critical care tests and rapid point-of-care tests for Heartworm infections, Parvovirus, Giardia, Ehrlichia and Lyme disease.  Abaxis, through its AVRL division, provides routine laboratory testing as well as specialty testing for veterinarians nationwide.

Contact:	Clint Severson	Lytham Partners, LLC
	Chief Executive Officer	Joe Dorame, Joe Diaz & Robert Blum
	Abaxis, Inc.	602-889-9700
	510-675-6500

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/abaxis-to-report-third-quarter-fiscal-year-2015-financial-results-thursday-january-29-2015-300021676.html

SOURCE Abaxis, Inc.

Copyright 2015 PR Newswire